ATE348892T1 - Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen - Google Patents

Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen

Info

Publication number: ATE348892T1
Authority: AT; Austria
Prior art keywords: protease; pneumoniae; chlamydia; strain; host
Prior art date: 2000-05-08

Application number

AT01931274T

Other languages

English (en)

Inventor

Andrew D Murdin

Raymond P Oomen

Joe Wang

Pamela Dunn

Original Assignee

Sanofi Pasteur Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-08

Filing date

2001-05-08

Publication date

2007-01-15

2001-05-08 Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd

2007-01-15 Application granted granted Critical

2007-01-15 Publication of ATE348892T1 publication Critical patent/ATE348892T1/de

Links

241000606161 Chlamydia Species 0.000 title abstract 2
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
239000012634 fragment Substances 0.000 title 1
241001647372 Chlamydia pneumoniae Species 0.000 abstract 3
108090000860 Endopeptidase Clp Proteins 0.000 abstract 2
108091005804 Peptidases Proteins 0.000 abstract 2
239000004365 Protease Substances 0.000 abstract 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
102000039446 nucleic acids Human genes 0.000 abstract 2
108020004707 nucleic acids Proteins 0.000 abstract 2
150000007523 nucleic acids Chemical class 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
239000013598 vector Substances 0.000 abstract 2
102100021501 ATP-binding cassette sub-family B member 5 Human genes 0.000 abstract 1
-1 DNA Chemical class 0.000 abstract 1
108010059378 Endopeptidases Proteins 0.000 abstract 1
102000005593 Endopeptidases Human genes 0.000 abstract 1
101000677872 Homo sapiens ATP-binding cassette sub-family B member 5 Proteins 0.000 abstract 1
102000005741 Metalloproteases Human genes 0.000 abstract 1
108010006035 Metalloproteases Proteins 0.000 abstract 1
108091005461 Nucleic proteins Proteins 0.000 abstract 1
108090000279 Peptidyltransferases Proteins 0.000 abstract 1
102000002933 Thioredoxin Human genes 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
238000002649 immunization Methods 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
239000002773 nucleotide Substances 0.000 abstract 1
125000003729 nucleotide group Chemical group 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
230000003248 secreting effect Effects 0.000 abstract 1
108060008226 thioredoxin Proteins 0.000 abstract 1
229940094937 thioredoxin Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)

AT01931274T 2000-05-08 2001-05-08 Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen ATE348892T1 (de)

Applications Claiming Priority (10)

Application Number	Priority Date	Filing Date
US20267200P	2000-05-08	2000-05-08
US20785200P	2000-05-30	2000-05-30
US21180100P	2000-06-16	2000-06-16
US21204400P	2000-06-16	2000-06-16
US21179600P	2000-06-16	2000-06-16
US21179800P	2000-06-16	2000-06-16
US21179700P	2000-06-16	2000-06-16
US23536100P	2000-09-26	2000-09-26
US23539800P	2000-09-26	2000-09-26
US23533500P	2000-09-26	2000-09-26

Publications (1)

Publication Number	Publication Date
ATE348892T1 true ATE348892T1 (de)	2007-01-15

Family

ID=27581138

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01931274T ATE348892T1 (de)	2000-05-08	2001-05-08	Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen

Country Status (6)

Country	Link
EP (1)	EP1282718B1 (de)
AT (1)	ATE348892T1 (de)
AU (1)	AU2001258105A1 (de)
CA (1)	CA2408199A1 (de)
DE (1)	DE60125350T2 (de)
WO (1)	WO2001085972A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000011181A1 (en)	1998-08-20	2000-03-02	Connaught Laboratories Limited	NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
EP1105489A1 (de)	1998-08-20	2001-06-13	Aventis Pasteur Limited	Nukleinsäuren kodierend für pomp91a aus chlamydia
US6686339B1 (en)	1998-08-20	2004-02-03	Aventis Pasteur Limited	Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
US6649370B1 (en)	1998-10-28	2003-11-18	Aventis Pasteur Limited	Chlamydia antigens and corresponding DNA fragments and uses thereof
US6607730B1 (en)	1998-11-02	2003-08-19	Aventis Pasteur Limited/Aventis Pasteur Limitee	Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2353107A1 (en)	1998-12-01	2000-06-08	Andrew D. Murdin	Chlamydia antigens and corresponding dna fragments and uses thereof
JP2002531129A (ja)	1998-12-08	2002-09-24	コリクサコーポレイション	クラミジア感染の処置および診断のための化合物および方法
US20020061848A1 (en)	2000-07-20	2002-05-23	Ajay Bhatia	Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en)	1998-12-18	1999-02-10	Chiron Spa	Antigens
US7297341B1 (en)	1998-12-23	2007-11-20	Sanofi Pasteur Limited	Chlamydia antigens and corresponding DNA fragments and uses thereof
JP2002541766A (ja)	1998-12-28	2002-12-10	アベンティス、パストゥール、リミテッド	クラミジア抗原および対応するｄｎａ断片ならびにその使用
US6808713B1 (en)	1998-12-28	2004-10-26	Aventis Pasteur Limited	Chlamydia antigens and corresponding DNA fragments and uses thereof
GB9902555D0 (en)	1999-02-05	1999-03-24	Neutec Pharma Plc	Medicament
MXPA01009256A (es)	1999-03-12	2003-07-14	Aventis Pasteur	Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
DE60036698T2 (de)	1999-05-03	2008-07-24	Sanofi Pasteur Ltd., Toronto	Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
NZ517952A (en)	1999-09-20	2004-01-30	Aventis Pasteur	Chlamydia antigens and corresponding DNA fragments and uses thereof
US6632663B1 (en)	1999-09-22	2003-10-14	Aventis Pasteur Limited	DNA immunization against chlamydia infection
EP1240331B1 (de)	1999-12-22	2010-04-07	Aventis Pasteur Limited	Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
WO2001081379A2 (en)	2000-04-21	2001-11-01	Corixa Corporation	Compounds and methods for treatment and diagnosis of chlamydial infection
AU2001258105A1 (en)	2000-05-08	2001-11-20	Aventis Pasteur Limited	Chlamydia antigens and corresponding dna fragments and uses thereof
JP2004502415A (ja)	2000-07-03	2004-01-29	カイロン　エセ．ピー．アー．	Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅに対する免疫化
US20030059896A1 (en) *	2000-12-21	2003-03-27	Shire Biochem Inc.	Novel chlamydia antigens and corresponding DNA fragments
US8568732B2 (en)	2009-03-06	2013-10-29	Novartis Ag	Chlamydia antigens

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002536958A (ja) *	1997-11-21	2002-11-05	ジェンセット	Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅゲノム配列およびポリペプチド、それらのフラグメント、ならびに特に感染症の診断、予防および治療のためのそれらの使用
CA2350775A1 (en)	1998-11-12	2000-05-18	The Regents Of The University Of California	Chlamydia pneumoniae genome sequence
US20020061848A1 (en)	2000-07-20	2002-05-23	Ajay Bhatia	Compounds and methods for treatment and diagnosis of chlamydial infection
US6565856B1 (en)	1998-12-08	2003-05-20	Corixa Corporation	Compounds and methods for treatment and diagnosis of chlamydial infection
JP2002531129A (ja)	1998-12-08	2002-09-24	コリクサコーポレイション	クラミジア感染の処置および診断のための化合物および方法
GB9828000D0 (en)	1998-12-18	1999-02-10	Chiron Spa	Antigens
GB9902555D0 (en)	1999-02-05	1999-03-24	Neutec Pharma Plc	Medicament
DE60036698T2 (de)	1999-05-03	2008-07-24	Sanofi Pasteur Ltd., Toronto	Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
NZ517952A (en)	1999-09-20	2004-01-30	Aventis Pasteur	Chlamydia antigens and corresponding DNA fragments and uses thereof
US6632663B1 (en)	1999-09-22	2003-10-14	Aventis Pasteur Limited	DNA immunization against chlamydia infection
EP1240331B1 (de)	1999-12-22	2010-04-07	Aventis Pasteur Limited	Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
WO2001081379A2 (en)	2000-04-21	2001-11-01	Corixa Corporation	Compounds and methods for treatment and diagnosis of chlamydial infection
AU2001258105A1 (en)	2000-05-08	2001-11-20	Aventis Pasteur Limited	Chlamydia antigens and corresponding dna fragments and uses thereof
JP2004502415A (ja)	2000-07-03	2004-01-29	カイロン　エセ．ピー．アー．	Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅに対する免疫化

2001
- 2001-05-08 AU AU2001258105A patent/AU2001258105A1/en not_active Abandoned
- 2001-05-08 CA CA002408199A patent/CA2408199A1/en not_active Abandoned
- 2001-05-08 WO PCT/CA2001/000653 patent/WO2001085972A2/en not_active Ceased
- 2001-05-08 AT AT01931274T patent/ATE348892T1/de not_active IP Right Cessation
- 2001-05-08 EP EP01931274A patent/EP1282718B1/de not_active Expired - Lifetime
- 2001-05-08 DE DE60125350T patent/DE60125350T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2408199A1 (en)	2001-11-15
EP1282718A2 (de)	2003-02-12
WO2001085972A2 (en)	2001-11-15
DE60125350D1 (de)	2007-02-01
DE60125350T2 (de)	2007-07-12
WO2001085972A3 (en)	2002-08-08
EP1282718B1 (de)	2006-12-20
AU2001258105A1 (en)	2001-11-20

Legal Events

Date	Code	Title	Description
2007-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE348892T1 (de)	2007-01-15	Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
Negri et al.	2013	Expression and display of Clostridium difficile protein FliD on the surface of Bacillus subtilis spores
WO2002018595A3 (en)	2002-10-03	Moraxella polypeptides and corresponding dna fragments and uses thereof
WO2002070652A3 (en)	2005-11-24	Novel molecules of the card-related protein family and uses thereof
WO2002008277A3 (en)	2003-01-30	Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2001075112A3 (en)	2002-02-28	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001074863A3 (en)	2002-08-01	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001046225A3 (en)	2001-12-06	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075111A3 (en)	2002-01-24	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075114A3 (en)	2002-08-01	Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
Goswami et al.	1996	Molecular Cloning ofClostridium perfringensEpsilon-Toxin Gene and Its High Level Expression inE. coli
Bannantine et al.	2008	Development and use of a partial Mycobacterium avium subspecies paratuberculosis protein array
EP2172214A3 (de)	2011-03-16	Chlamydia-Antigene und entsprechende DNA-Fragmente sowie Verwendungen davon
MXPA04004561A (es)	2004-09-10	Distribuidor de aire para sistema de biolixiviacion.
EP1792995A3 (de)	2007-06-13	Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
WO2003031594A3 (en)	2005-01-27	Nucleotide and amino acid sequences relating to respiratory diseases and obesity
WO2000006742A3 (en)	2000-04-27	Chlamydia antigens and corresponding dna fragments and uses thereof
MXPA01004353A (es)	2002-07-22	Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2003029434A3 (en)	2003-10-16	Novel molecules of the hkid-1-related protein family and uses thereof
WO2002002771A3 (en)	2003-01-23	Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
WO2002012475A3 (en)	2003-05-15	C1q-related factor, homologous polypeptides and therapeutic uses thereof
WO2000026237A3 (en)	2000-09-21	Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof
MXPA01001639A (es)	2004-09-06	Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2003020912A3 (en)	2003-08-28	Novel clark protein and nucleic acid molecules and uses therefor
WO2001083523A3 (en)	2002-06-13	Stmst protein and nucleic acid molecules and uses therefor